Close

Vertex's (VRTX) ViaCyte Acquisition "Adds Additional Shots on Goal" - BMO Capital Reiterates Stock at Outperform with $325 Price Target Jul 11, 2022 11:33AM
BMO Capital Reiterates Outperform Rating, $325 Price Target on Vertex (VRTX) Following VX-880 Hold Lift Jul 5, 2022 11:07AM
BMO Capital Reiterates Vertex (VRTX) at Outperform with $274 Price Target, Sees Good Odds of Proteinuria-based Approval of VX-147 Mar 22, 2022 10:33AM
Vertex (VRTX) is a Clean Revenue Growth Story, Pipeline is Discounted and Stock Remains Preferred - BMO Capital Jan 26, 2022 04:46PM
UPDATE: BMO Capital Upgrades Vertex (VRTX) to Outperform Ahed of AbbVie Readout Jan 20, 2022 08:58AM


Nov 18, 2021 04:25PM UPDATE: BMO Capital Starts Vertex (VRTX) at Market Perform
Nov 19, 2019 03:55PM Vertex (VRTX) PT Raised to $248 at BMO Capital
Oct 22, 2019 07:41PM Vertex (VRTX) PT Raised to $240 at BMO Capital
Oct 21, 2019 10:50AM Vertex (VRTX) PT Trimmed to $232 at BMO Capital
Aug 1, 2019 06:53AM Vertex (VRTX) PT Raised to $235 at BMO Capital
Feb 6, 2019 07:53AM Vertex (VRTX) PT Raised to $234 at BMO Capital
Oct 25, 2018 07:24AM Vertex (VRTX) PT Lowered to $192 at BMO Capital
Jul 26, 2018 07:11AM Vertex (VRTX) PT Raised to $204 at BMO Capital; 'Stellar Revenue'
Jul 27, 2017 08:33AM Vertex Pharma (VRTX): Orkambi Beat Offset By Spending - BMO
Jul 19, 2017 06:43AM Vertex Pharma (VRTX): Raising PT Nearly 50% - BMO
Jul 18, 2017 08:55PM World stocks tally ninth day of gains as earnings pick up
Mar 29, 2017 03:20AM BMO Capital Upgrades Vertex (VRTX) to Outperform Following Tezacraftor Validation In Phase III
Mar 7, 2017 06:10AM BMO Capital Maintains Market Perform Rating and $78 PT on Vertex Pharma (VRTX) Following Concert CTP-656 Acquisition
Nov 29, 2016 07:56AM Vertex Pharma (VRTX): Nivalis Setback Positive For Orkambi - BMO
Oct 26, 2016 06:51AM Vertex (VRTX) PT Bumped to $88 at BMO Capital Following Results and Triple Combo Update
Aug 22, 2016 09:41AM Vertex (VRTX), BioMarin (BMRN), Intercept (ICPT), Others Highlighted as Targets at BMO Following PFE/MDVN
Apr 6, 2016 04:26PM BMO Capital Starts Vertex (VRTX) at Market Perform
Feb 1, 2016 10:38AM Notable Analyst Rating Changes 2/1: (JOY) (PFPT) (VRTX) Upgraded; (ARR) (GPC) (AIG) Downgraded
Sep 14, 2015 10:24AM Notable Analyst Rating Changes 9/14: (NOK) (VRTX) (EXC) Upgraded; (MRVL) (GFI) (ALXN) Downgraded
Apr 10, 2015 10:51AM Notable Analyst Rating Changes 4/10: (NFLX) (M) (KNX) Upgraded; (CAB) (HBHC) (AAPL) Downgraded
Oct 13, 2014 10:19AM Notable Analyst Rating Changes 10/13: (NAVI) (VRTX) (SFUN) Upgraded; (JCP) (ONNN) (PBF) Downgraded
Nov 28, 2012 10:45AM Notable Analyst Rating Changes 11/28: (AKAM) (AKS) (OMC) Upgraded; (CTL) (ESV) (VRTX) Downgraded
Aug 17, 2011 10:40AM Notable Analyst Rating Changes 08/17: (ECA) (ODP) (VRTX) Upgraded; (FSLR) (HPQ) (IMAX) Downgraded
Mar 8, 2011 10:49AM Notable Analyst Rating Changes 03/08: (NVDA) (EXPE) (MDC) Upgraded; (VRTX) (HK) (QCOM) Downgraded
Mar 8, 2011 07:19AM BMO Capital Downgrades Vertex (VRTX) to Market Perform